- In September 2024, Helaina completed a Series B funding round, raising USD 45 million, led by Avidity Partners. In addition, this funding boosts Helaina’s total equity funding to USD 83 million and will support the launch of their human lactoferrin product, branded as effera, aimed at the women’s health, active nutrition, and healthy aging markets
- In August 2024, De Novo Foodlabs, known for producing animal-free lactoferrin through precision fermentation, secured USD 1.5 million in seed funding, led by Joyful VC in California. In addition, this investment will help accelerate the commercialization of their product, NanoFerrin, enabling greater production scale and market reach within the food technology industry
- In February 2023, Morinaga Milk Industry Co., Ltd. acquired shares in Le May Production, a company specializing in the import and export of infant and toddler milk. In addition, this move aims to bolster the nutritional infrastructure in Asia
- In August 2022, Morinaga Milk Industry Co., Ltd. received FDA GRAS (Generally Recognized as Safe) approval for its Probiotic Bifidobacterium infantis M-63, which is now approved for use in infant formula and general foods
- In May 2022, Glanbia PLC acquired Sterling Technology, a U.S.-based producer of dairy bioactive solutions derived from bovine colostrum. In addition, this acquisition is part of Glanbia's strategy to expand its brand presence in the market
